Phase I/II clinical trial will be first of its kind to explore cannabis as a potential treatment option for essential tremor.
Cannabinoid drugs do not appear to reduce the intensity of experimental pain, but, instead, may make pain feel less unpleasant and more tolerable.
The authors behind the work believe that CBD may constitute an excellent candidate for the treatment of MS and other autoimmune diseases as a novel, non-psychoactive therapeutic.
This article highlights the areas where Illinois could make improvements in order to establish a more efficient and effective medicinal cannabis treatment program.
Self-reporting study fuels debate over the potential risks to mental health of long term, high THC concentrate use.
A clinical trial involving 20 Canadian children with severe intractable epilepsy has posted resulting indicating cannabis oil could reduce seizures by over 70%.
Study reveals sex-specific effects of prenatal cannabinoid exposure on adult offspring and identifies potential new therapeutic strategies.
It is reported that these failures are due to both the mislabeling of products and contamination from pesticides, bacteria, and processing chemicals.
Utilizing new mobile application technology, researchers at The University of New Mexico found that medical cannabis provides immediate symptom relief across dozens of health symptoms with relatively minimal negative side effects.